Who We Are

AHFS Drug Information is the premier drug information database, providing an evidence-based foundation for safe and effective drug therapy. We are committed to alerting our subscriber to the latest critical therapeutic developments

Product Spotlight

The 2008 AHFS Drug Information is the premier source of comprehensive, unbiased, evaluative drug data available for healthcare professionals today. Free online update are available to subscribers!

Drug Information For

Monograph Updates

AHFS Classification

Classification Changes

News

8/19	Deaths from Severe Acute Pancreatitis Reported with Exenatide Use [ASHPNews]
8/19	Firm Recalls Monoclate-P Vials [ASHPNews]
8/18	FDA Program Could Boost Treatments for Neglected Diseases [AJHP]
8/15	FDA Approves Tetrabenazine To Treat Chorea [ASHPNews]
8/15	Third Accreditation Option for Hospitals May Be Available Soon [AJHP]

Off Label Uses

AHFS DI is a tested and proven source of comparative, unbiased, and evidence-based drug information. Drug monographs, and final determinations specifically published for medically acceptable off-label uses, are prepared by a professional editorial and analytical staff, who critically evaluate published evidence on the drug. Read more.

Review the Oncology Determination Tables.

Search

Who We Are

Product Spotlight

Drug Information For

News

Off Label Uses